USC Atherosclerosis Research Unit
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2250 Alcazar St Ste 132, Los Angeles, Ca...Website
aru.usc.eduRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About USC Atherosclerosis Research Unit
The Atherosclerosis Research Unit (ARU) focuses on establishing national public health policies aimed at preventing cardiovascular disease, particularly targeting heart, stroke, and peripheral vascular diseases. They conduct studies, such as the APPT trial, to evaluate the effects of a new FDA-approved menopausal hormone therapy, bazedoxifene/estrogen, on atherosclerosis and related health issues in women with a uterus. Their research addresses critical concerns regarding menopausal health and cardiovascular risk, specifically for postmenopausal women who are significantly affected by atherosclerosis. Intended clients include women undergoing menopause, healthcare providers, and public health policymakers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is USC Atherosclerosis Research Unit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at USC Atherosclerosis Research Unit
Click to see if USC Atherosclerosis Research Unit had a recent Job posting/layoffs
Funding: Get notified immidiatlly once USC Atherosclerosis Research Unit has new funding data
USC Atherosclerosis Research Unit, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on USC Atherosclerosis Research Unit recently announced quarterly report
Check if USC Atherosclerosis Research Unit has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when USC Atherosclerosis Research Unit launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if USC Atherosclerosis Research Unit is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to USC Atherosclerosis Research Unit
Compare insights from companies similar to USC Atherosclerosis Research Unit, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
USC Atherosclerosis Resea...
<$5M
11-50
Private
-
1991
N/A
<$5M
1-10
Private
-
2003
SA
Sima AidunClinical Nutrigenomic Specialist, Integrative Endocrine Care, Naturopathic Medical Doctor
Company Profile Activity
Activity Insights
USC Atherosclerosis Research Unit is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
USC Atherosclerosis Research Unit is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about USC Atherosclerosis Research Unit.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding USC Atherosclerosis Research Unit
Sign Up For FreeTo access detailed company insights
The Atherosclerosis Research Unit (ARU) focuses on establishing national public health policies aimed at preventing cardiovascular disease, particularly targeting heart, stroke, and peripheral vascular diseases. They conduct studies, such as the APPT trial, to evaluate the effects of a new FDA-approved menopausal hormone therapy, bazedoxifene/estro... Read More
